3 reasons I'm not buying Medibank Private Ltd shares in 2017

Buyers of Medibank Private Ltd (ASX:MPL) today aren't getting that good a deal.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I think Medibank Private Ltd (ASX: MPL) is a good business. It has short-tail insurance liabilities usually up to one-year long, and has reasonably reliable business due to the safety net it offers customers.

Premiums receive legislated increases annually in order to cover rises in healthcare costs, and the government increasingly intends to shift more people to the private health system – this is the reasoning behind the Medicare Levy Surcharge and the government's Private Health Insurance Rebate.

On top of that, Medibank gets to invest any unclaimed premiums for its own benefit, resulting in an investment portfolio growing steadily larger. It's a good gig, but I'm not a buyer right now for three key reasons:

  • The company is losing market share to competitors
  • Medibank reportedly has terrible customer service, recently accounting for a major chunk of total industry complaints to the Private Health Insurance Ombudsman (PHIO)
  • It is reinvesting heavily in improving the value offered to policyholders, as well as improving customer service

In my earlier article (hyperlink above) I pointed out the seeming oxymoron of simultaneously attempting to improve value for customers and investing heavily in customer service while attempting to maintain market-leading profit margins.

Medibank's strategy appears to be a solid one over the longer term, where it should result in happier and more loyal customers (and hopefully more of them), but I expect it to result in short-term pain to profits and continued problems for customers as new staff are trained and IT issues resolved.

My concern is that these issues are not reflected in the share price; in fact Medibank shares have risen in recent times as investors bank on higher interest rates (government 10-year bond yields have been rising since September). So investors are looking at a company with problems, likely flat or possibly lower profits, and with some of the potential upside from higher interest rates already built into the price.

Medibank is a good business, but I don't believe it is good value today. I continue to think it is a 'Hold'.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »